Slideshow

Antipsychotics-To Respond or Not to Respond?

Author(s):

Brian Miller, MD, PhD, MPH

A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.

Related Videos
Meyer
emergency
schizophrenia
sc
schizophrenia
clozapine
brain
cognition
clock
Related Content
sleepy somnolence
May 29th 2025

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
May 28th 2025

The Enduring Impact of Early Adversity on Psychosis Risk

Nicole R. Karcher, PhD, MA
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
schizophrenia
May 23rd 2025

Coordinated Specialty Care: Paving the Way for Psychosis Recovery

Alia R. Warner, PhD Shirley Glynn, PhD L. Elliot Hong, MD
schizophrenia
May 22nd 2025

Major Changes in the Treatment of Schizophrenia: A Long Time in the Making

Peter J. Weiden, MD
© 2025 MJH Life Sciences

All rights reserved.